Unnamed Pharmaceuticals: Supervisory Board\'s Review Opinions on the List of Incentives Awarded by the Company\'s 2023 Stock Option Incentive Plan

SZSI · May 30, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.